Stock Spotlight: ASX Limited (ASX:ASX)

This week's Stock Spotlight is ASX-listed ASX Limited.


About ASX Limited.


ASX Limited operates as a multi-asset class and integrated exchange company in Australia and internationally. The company provides education programs, research and insights, investor access and peer group networking; distribution facility for quoted exchange traded funds (ETFs) and debt securities. It is also involved in the trading of futures and options on interest rate, equity index, agricultural and energy products, and options over individual securities; cash market trading of equities, warrants, exchange-traded funds, and debt securities; and clearing of exchange-traded derivatives and over-the-counter interest rate and equity derivatives. In addition, it offers information services, including pricing and trading data; technical services, such as s market access, connectivity, hosting and co-location services; central counterparty clearing and settlement services for equities; settlement, depository, and registry services for debt securities; and payment platform for property transactions, high value payments and electricity providers. The company was incorporated in 1987 and is based in Sydney, Australia.


Source: Yahoo Finance



Key Stats

Source: Yahoo Finance, ASX. Data as of 04/08/25.


Price Performance

Growth Potential

  • Value accretive M&A
  • Product and service innovation (e.g. new trading products).
  • Monopoly-like position and difficult to replicate infrastructure.
  • Better than expected volume growth in IPO and secondary markets.
  • High operating margins with attractive cash producing profile.
  • Investment in technology could yield additional value and revenue opportunities.
  • ASX benefits from higher interest rates – ASX benefits from higher income on own cash and on participants balances (earns a spread).
  • Strong balance sheet with net cash and AA-credit rating.
  • ASX stands to benefit from growth trends in superannuation and population.
  • ASX stands to benefit from structural growth from global connectivity.
  • Consolidation or M&A potential.

Key Risks


  • Capex execution risks with ROIC falling short of expectations.
  • Expenses growth ahead of expectations.
  • Expectations of subdued volume growth and earnings outlook.
  • Technological and product innovation by competitors or a new start-up could potentially threaten ASX’s market monopoly.
  • Regulation risks.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.
September 9, 2026
Copper is at a record high, yet the global market still has a surplus. So where is all the copper, and why is it becoming harder to find?
By Lavender Wong September 1, 2026
Sharewise CEO Alex Perry sat down with ausbiz to unpack how the platform approached FY26, a year in which it reported an ASX return of almost 11% and a US return above 32%. The conversation ranged from the AI infrastructure theme to specific names on Perry's radar in resources and quantum computing. Here's a rundown of the key points.
August 31, 2026
Warsh gave markets a framework, not a forecast. What his first Jackson Hole keynote means for inflation, rates, forward guidance and the outlook for equities.
August 26, 2026
Get the latest on Impact Minerals (ASX: IPT), including stock performance, technical analysis, forecasts & key insights. See if IPO supports your goals.
August 26, 2026
Get the latest on Valiant Gold (ASX: VAL) with our share price, technical analysis, forecasts & key insights. See if this ASX gold stock fits your investment goals.
August 26, 2026
Learn about Percheron Therapeutics (ASX: PER). Offering share price, technical analysis, forecasts & insights. See if this ASX biotech stock fits your goals.
August 19, 2026
Brent crude hits US$91 as US-Iran talks stall and Strait of Hormuz disruption persists. What's driving the move and what comes next for oil
August 13, 2026
The RBA holds rates at 4.35% as inflation remains elevated. Here’s what the August decision means for the Australian economy, markets and key sectors.
August 6, 2026
As AI becomes cheaper to deploy, could the next investment winners shift beyond chipmakers? Explore how the AI cost race is redefining future tech leaders.